Does your child have Atopic Dermatitis (AD)?
Atopic dermatitis (AD), the most common form of eczema, is a chronic inflammatory skin disorder that affects individuals of all ages, ethnicities, and geographic regions worldwide.
We are currently recruiting children aged 3 to 23 months with Atopic Dermatitis (Eczema) to participate in an investigational study.
The study is being done to investigate the safety and efficacy of the investigational drug tapinarof Cream, 1%. The study drug is a topical cream and the treatment is experimental.
Your child will be provided with all study-related medication, examinations, and any care will be provided at no cost to you.
Join the trial to contribute to the development of this treatment and potentially benefit from its effects.
